Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-11-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Clindamycin And Benzoylperoxide, Atc D10af54 2025-11-16
Germany Medicines With The Active Ingredient Apremilast (atc 2025-11-16
Germany Open House Medicinal Properties Icatibant, Atc B06ac02 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V To The Active Ingredient Sapropter (exclusively Dosage Form Ple), Atc A16ax07 For The Time 01.07.2025 - 30.06.2027 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Lapatinib, Atc L01eh01 For The Time 01.07.2025 - 30.06.2027 (plus Extension Option 1x 12 Months) 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Cabotegravir, Atc J05aj04 For The Period 01.07.2025 - 30.06.2027 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Rilpivirin, Atc J05ag05 For The Period 01.07.2025 - 30.06.2027 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Carglum Acid, Atc A16aa05 For The Period 01.07.2025 - 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V To The Active Ingredient Glatirameracetate (exclusively Dosage Form), Atc L03ax13 For The Time 01.07.25 - 30.06.27 2025-11-16
Whats app